After Wellcome's death, the income from the Foundation, initially via dividends, later via more tax efficient deeds of covenant, was used to fund the Wellcome Trust, providing endowments for pharmacology departments to educate and train the researchers of the future. After changes in UK charity law the Foundation was sold to GSK and the receipts invested in a broad ranging portfolio. The Trust then became the largest charity in the UK, providing funding for focus areas such as biomedical science, technology transfer, public engagement and bioethics. Grants and fellowships are available to recipients with goals of translating research into usable health products. The trust currently spends over $600 million a year in medical research training.